{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigvc2hla7muo2yoha5zhxabqdczi2v45cgjrj5d2h2udtc3t5myb4",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3mmlfm7aiiwe2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibwbriqbudiommjvyhcf54zbailliu6klawpfqhuwot7dq2d6lqty"
    },
    "mimeType": "image/jpeg",
    "size": 175058
  },
  "path": "/new-anti-clotting-medication-prevents-strokes-without-the-usual-bleeding-risk/",
  "publishedAt": "2026-05-24T05:45:55.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "Blood Clots",
    "Cardiology",
    "McMaster University",
    "Neurology",
    "Stroke"
  ],
  "textContent": "A major international trial suggests an experimental anti-clotting drug may lower the risk of repeat strokes without the dangerous bleeding complications tied to many current treatments. For decades, stroke specialists have faced a frustrating tradeoff: stronger anti-clotting drugs can reduce the risk of another stroke, but they also raise the danger of serious bleeding. Now, [...]",
  "title": "New Anti-Clotting Medication Prevents Strokes Without the Usual Bleeding Risk"
}